| 10430536
|
Application of oral bioavailability surrogates in the design of orally active inhibitors of rhinovirus replication. |
J Pharm Sci |
1999 |
Stratford RE Jr;Clay MP;Heinz BA;Kuhfeld MT;Osborne SJ;Phillips DL;Sweetana SA;Tebbe MJ;Vasudevan V;Zornes LL;Lindstrom TD |
View
More |
| 13678411
|
Imidazo[1,2-b]pyridazines, novel nucleus with potent and broad spectrum activity against human picornaviruses: design, synthesis, and biological evaluation. |
J Med Chem |
2003 |
Hamdouchi C;Sanchez-Martinez C;Gruber J;Del Prado M;Lopez J;Rubio A;Heinz BA |
View
More |
| 214563
|
Imidazo[1,2-a]-s-triazine nucleosides. Synthesis and antiviral activity of the N-bridgehead guanine, guanosine, and guanosine monophosphate analogues of imidazo[1,2-a]-s-triazine. |
J Med Chem |
1978 |
Kim SH;Bartholomew DG;Allen LB;Robins RK;Revankar GR |
View
More |
| 4339771
|
Azapurine nucleosides. 3. Synthesis of 7-( -D-ribofuranosyl)imidazo(4,5-d)-v-triazin-4-one(2-azainosine) and related derivatives. |
J Med Chem |
1972 |
Kawana M;Ivanovics GA;Rousseau RJ;Robins RK |
View
More |
